Discover

DMAA
Drugs Made In America Acquisition Corp.
10.84
5 x 10.65
5 x 10.54
bid
ask
+
0.00
0.00%
5 @ 04:00 PM
10.84 +0.00 (0.00%)
Ytd4.53%
1y5.45%
10.84
day range
10.84
10.26
52 week range
10.84
Open10.84Prev Close10.84Low10.84High10.84Mkt Cap263.16M
Vol352.00Avg Vol35.82KEPS0.18P/E60.22Forward P/EN/A
Beta0.01Short RatioN/AInst. OwnN/ADividendN/ADiv YieldN/A
Ex Div DateN/AEarning05-2050-d Avg10.73200-d Avg10.551yr Est0.00
Income Statement
Operating Expenses136.93K
Selling, General and Administrative Expense136.93K
Operating Income-136.93K
Net Income1.73M
Net Income Common Stock1.73M
Net Income Common Stock (USD)1.73M
Consolidated Income1.73M
Earnings per Basic Share0.06
Earnings per Basic Share (USD)0.06
Earnings per Diluted Share0.06
Earning Before Interest & Taxes (EBIT)1.73M
Earning Before Interest & Taxes (USD)1.73M
Weighted Average Shares30.81M
Weighted Average Shares Diluted30.81M
Balance Sheet
Cash and Equivalents20.28K
Cash and Equivalents (USD)20.28K
Investments146.83M
Investments Non-Current146.83M
Current Assets69.18K
Total Assets146.90M
Debt Current950.00K
Total Debt950.00K
Current Liabilities2.94M
Total Liabilities9.14M
Accumulated Retained Earnings (Deficit)-7.41M
Shareholders Equity-7.41M
Shareholders Equity (USD)-7.41M
Assets Non-Current146.83M
Total Debt (USD)950.00K
Liabilities Non-Current6.19M
Trade and Non-Trade Payables254.41K
Cash Flow
Net Cash Flow from Financing-98.46M
Net Cash Flow / Change in Cash & Cash Equivalents5.39K
Issuance (Purchase) of Equity Shares-99.31M
Issuance (Repayment) of Debt Securities 250.00K
Net Cash Flow from Investing98.71M
Net Cash Flow - Investment Acquisitions and Disposals98.71M
Net Cash Flow from Operations-244.61K